Skip to content

Drug Toxicology and Safety Pharmacology MSc

Duration
1 year
1 year
Start date
September
September
Location
City Campus
City Campus
Make an enquiryMake an enquiry

Suitable for UK and internationalUK and international applications.

This full-time Master's programme provides a comprehensive overview of drug safety practices within the drug development process.

It addresses key aspects of preclinical drug evaluation through the study of:

  • Drug discovery and development
  • Safety pharmacology
  • Mechanisms of drug-induced toxicities
  • Regulatory affairs
  • Bioanalytical sciences

It will give you state-of-the-art training in preclinical toxicology, with an emphasis on the molecular in vitro and in vivo aspects of toxicology and safety pharmacology assessments.

As part of the programme you will undertake an original research project that will be the basis of your dissertation.

Delivered at the Institute of Cancer Therapeutics, an internationally renowned research institution, the programme gives you the skills you need for a career in the pharmaceutical industry or regulatory bodies, along with the foundations for PhD study.

Drug toxicology and safety pharmacology lies at the heart of the chemical and pharmaceutical industries, and demand for highly skilled practitioners in this field is extremely high.

This full-time Master's programme provides a comprehensive overview of drug safety practices within the drug development process.

It addresses key aspects of preclinical drug evaluation through the study of:

  • Drug discovery and development
  • Safety pharmacology
  • Mechanisms of drug-induced toxicities
  • Regulatory affairs
  • Bioanalytical sciences

It will give you state-of-the-art training in preclinical toxicology, with an emphasis on the molecular in vitro and in vivo aspects of toxicology and safety pharmacology assessments.

As part of the programme you will undertake an original research project that will be the basis of your dissertation.

Delivered at the Institute of Cancer Therapeutics, an internationally renowned research institution, the programme gives you the skills you need for a career in the pharmaceutical industry or regulatory bodies, along with the foundations for PhD study.

Drug toxicology and safety pharmacology lies at the heart of the chemical and pharmaceutical industries, and demand for highly skilled practitioners in this field is extremely high.

Entry requirements

Entry requirements

To be admitted to the programme, applicants must have an undergraduate Honours qualification (minimum 2: 2) or equivalent in a scientific discipline, usually within chemistry, biology, pharmacy, biomedicine, or related fields. Candidates who do not meet these entry criteria but who can show relevant experience may also be considered.

For North American students a GPA of normally 2.0 and above (on a scale of 4.0), or an equivalent, is required.

To be admitted to the programme, applicants must have an undergraduate Honours qualification (minimum 2: 2) or equivalent in a scientific discipline, usually within chemistry, biology, pharmacy, biomedicine, or related fields. Candidates who do not meet these entry criteria but who can show relevant experience may also be considered.

For North American students a GPA of normally 2.0 and above (on a scale of 4.0), or an equivalent, is required.

English language requirements

If your native language is not English, or official language of your first degree is not English, you will need to pass a test in English approved by the University before you can be admitted. The International English Language Testing System test (IELTS) administered by the British Council is the test which is preferred by the University.

You will need to achieve an overall score of at least 6.0, with at least 5.5 in each of the four sub-tests (speaking, listening, reading, writing). Testing facilities are available at most British Council overseas offices. When you take the test, you should ask for a copy of your Test Report Form to be sent to the University.

English language requirements

If your native language is not English, or official language of your first degree is not English, you will need to pass a test in English approved by the University before you can be admitted. The International English Language Testing System test (IELTS) administered by the British Council is the test which is preferred by the University.

You will need to achieve an overall score of at least 6.0, with at least 5.5 in each of the four sub-tests (speaking, listening, reading, writing). Testing facilities are available at most British Council overseas offices. When you take the test, you should ask for a copy of your Test Report Form to be sent to the University.

Teaching, learning and assessment

A wide variety of teaching methods appropriate to the learning outcomes of the individual modules are employed throughout the programme and are supported by the virtual learning environment provided by the University.

Students will experience lectures from ICT research/teaching staff and visiting clinicians and industrial researchers, small group workshops, one-to-one tutorials and practical classes.

Students will also attend the Institute of Cancer Therapeutics Research Seminar programme. Self-directed independent learning forms a significant component at MSc level; students will be supported to develop the attributes and skills needed for life-long learning and continued professional development.

Directed private study will involve students in a variety of activities, which include directed reading of selected textbooks and specified source literature, use of the virtual learning environment (directed web-based materials), report writing, preparing presentations to deliver to peers, and other assignments.

Teaching, learning and assessment

A wide variety of teaching methods appropriate to the learning outcomes of the individual modules are employed throughout the programme and are supported by the virtual learning environment provided by the University.

Students will experience lectures from ICT research/teaching staff and visiting clinicians and industrial researchers, small group workshops, one-to-one tutorials and practical classes.

Students will also attend the Institute of Cancer Therapeutics Research Seminar programme. Self-directed independent learning forms a significant component at MSc level; students will be supported to develop the attributes and skills needed for life-long learning and continued professional development.

Directed private study will involve students in a variety of activities, which include directed reading of selected textbooks and specified source literature, use of the virtual learning environment (directed web-based materials), report writing, preparing presentations to deliver to peers, and other assignments.

Terms and conditions of study

The University has a set of terms and conditions for all students accepting an offer to study on a course here at Bradford. This is called The Student Contract. This document sets out the Terms and Conditions which apply when you accept an offer of a place on a programme of study at the University of Bradford.

View our Student Contract for further details.

Transparency statement

Information about this programme and its modules has been published in advance of the academic year to which it applies. Every effort has been made to ensure that the information is accurate at the time of publication, but changes may occur given the interval between publishing and commencement of teaching. Any change which impacts the terms and conditions of an applicant’s offer will be communicated to them.

Please apply online.

We will also need the following supporting documents, along with any other information specified on the course page:

  • Degree certificates/transcripts
  • Research proposal (if required)
  • Evidence of English language level (if required)
  • A copy of your passport

Current University of Bradford students can apply for a taught Master's course using our Fast-Track application form.

Apply